MOH vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

MOH

37.8
AI Score
VS
MOH Wins

CLOV

34.3
AI Score

Investment Advisor Scores

MOH

38score
Recommendation
SELL

CLOV

34score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MOH CLOV Winner
Forward P/E 38.1679 81.9672 MOH
PEG Ratio 1.7888 0 Tie
Revenue Growth -5.7% 55.6% CLOV
Earnings Growth -75.3% 0.0% CLOV
Tradestie Score 37.8/100 34.3/100 MOH
Profit Margin -0.0% -0.7% MOH
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

MOH 1M: +0.5% · 3M: +7.8% CLOV 1M: -4.9% · 3M: +15.8%

Current Technical Phase

MOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.0 · Price: $198.50

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $4.11

Fundamentals Snapshot

Metric MOH CLOV
Market Cap
Forward P/E 23.2 27.4
Trailing P/E 1251.8
Revenue (TTM)
Revenue Growth -0.1% 0.6%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS 0.16 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MOH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.